Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience
Maël Heiblig(Université Claude Bernard Lyon 1), Xavier Thomas(Hospices Civils de Lyon), Marie Balsat(Hôpital Claude Huriez), Adriana Pleșa(Hospices Civils de Lyon), Mohamed Elhamri(Hôpital Edouard Herriot), Fiorenza Barraco(Hôpital Lyon Sud), Eric Wattel(Hospices Civils de Lyon), Isabelle Tigaud(Inserm), Franck E. Nicolini(Université Claude Bernard Lyon 1), Gilles Salles(Memorial Sloan Kettering Cancer Center), Caroline Le Jeune(Hospices Civils de Lyon), Hélène Labussière(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud)
Cited by 12
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|Advances in Therapy|2017|603